Helios

Dragon Pharma Helios – Synergistic Clenbuterol & Yohimbine Blend

Dragon Pharma Helios is a specialized injectable formulation combining two synergistic lipolytic agents: Clenbuterol HCl (80 mcg/mL) and Yohimbine HCl (5 mg/mL). This unique blend is designed for research into adipose tissue metabolism, thermogenesis, and catecholamine-mediated lipolysis pathways. Each milliliter delivers this precise ratio of actives dissolved in premium MCT oil for consistent delivery in research protocols.

Helios combines two distinct mechanisms of action for enhanced lipolytic research. Clenbuterol is a selective beta-2 adrenergic agonist that stimulates thermogenesis and lipolysis through cAMP-dependent pathways. Yohimbine is an alpha-2 adrenergic antagonist that blocks the negative feedback inhibition of norepinephrine on fat cells, particularly in stubborn adipose depots. Together, these compounds provide dual-pathway activation of lipolysis for comprehensive adipose research. For researchers investigating synergistic lipolytic mechanisms, catecholamine signaling pathways, or combination strategies for adipose research, Dragon Pharma Helios delivers a ready-to-use blended formulation. When researchers seek legit Helios blend for advanced lipolysis studies, Dragon Pharma provides batch-traceable, third-party verified compounds.

Why Athletes & Bodybuilders Are Researching Helios Blend

Within performance research communities, the Helios blend is studied for its dual-mechanism approach to lipolysis. Research focuses on the synergistic effects of beta-2 agonism (Clenbuterol) and alpha-2 antagonism (Yohimbine) on adipose mobilization, particularly in research models of stubborn fat deposits. The injectable formulation provides localized and systemic research applications.

What Makes Dragon Pharma Helios Different?

• ✔ Dual mechanism synergy – Beta-2 agonist (Clenbuterol) + alpha-2 antagonist (Yohimbine) for comprehensive lipolysis research.
• ✔ Precision 80 mcg / 5 mg ratio – Optimized blend ratio for synergistic research applications.
• ✔ Oil-based formulation – MCT oil vehicle for stable, consistent delivery in research protocols.
• ✔ Single-vial convenience – Pre-blended formulation eliminates need for separate compound handling.

For researchers requiring a comprehensive lipolysis research tool with dual adrenergic pathway activation, legit Helios from Dragon Pharma delivers a professionally formulated, lab-verified blend.

Product Specifications

Dosage & Research Guidelines

Research Dosing Guidelines

Helios combines two active compounds with distinct mechanisms. Typical research dosing requires consideration of both components. Common research protocols utilize daily subcutaneous administration for localized or systemic lipolysis studies.

• ✔ Dual mechanism for comprehensive lipolysis research – Beta-2 agonism + alpha-2 antagonism
• ✔ One 10 mL vial provides 800 mcg Clenbuterol + 50 mg Yohimbine total
• ✔ Research cycles typically run 4-6 weeks for lipolysis studies
• ✔ Daily administration common due to moderate duration of action

Dosing Volume Guide

Using a standard 1 mL insulin syringe with Helios (80 mcg Clenbuterol + 5 mg Yohimbine per mL):

• ✔ 0.1 mL = 8 mcg Clenbuterol + 0.5 mg Yohimbine
• ✔ 0.2 mL = 16 mcg Clenbuterol + 1 mg Yohimbine
• ✔ 0.3 mL = 24 mcg Clenbuterol + 1.5 mg Yohimbine
• ✔ 0.4 mL = 32 mcg Clenbuterol + 2 mg Yohimbine
• ✔ 0.5 mL = 40 mcg Clenbuterol + 2.5 mg Yohimbine
• ✔ 0.6 mL = 48 mcg Clenbuterol + 3 mg Yohimbine
• ✔ 0.8 mL = 64 mcg Clenbuterol + 4 mg Yohimbine
• ✔ 1.0 mL = 80 mcg Clenbuterol + 5 mg Yohimbine
• ✔ Administer subcutaneously or intramuscularly using aseptic technique

How Researchers Are Using Helios Blend

Helios is valued in research for its dual-mechanism approach to lipolysis, combining beta-2 agonism with alpha-2 antagonism in a single formulation. Researchers study its effects on adipose mobilization, thermogenesis, and catecholamine signaling pathways.

Popular research stacks include:

• ✔ Helios + T3 (Liothyronine) – for combined lipolysis and metabolic rate research. View T3 →
• ✔ Helios + GW501516 – for lipid metabolism and endurance research protocols. View GW501516 →
• ✔ Helios + Clenbuterol – for dose-response studies with standardized yohimbine background. View Clenbuterol →

Research Protocol Example (6 Weeks)

• ✔ Weeks 1-6: Helios – 0.3-0.5 mL (24-40 mcg Clen / 1.5-2.5 mg Yoh) administered daily via subcutaneous injection
• ✔ Weeks 1-6: T3 – 25-50 mcg daily (optional for metabolic rate studies)
• ✔ Washout period: 7-10 days for complete clearance

Important Considerations

• 🔬 Dual mechanism: Clenbuterol (beta-2 agonist) stimulates lipolysis; Yohimbine (alpha-2 antagonist) blocks lipolysis inhibition – synergistic action
• 💧 Oil-based formulation provides sustained release compared to water-based alternatives
• ⚠️ Both compounds are beta-adrenergic modulators – relevant for cardiovascular research parameters
• 📦 Daily administration recommended for sustained lipolytic research protocols
• 📦 Always source Dragon Pharma Helios from verified suppliers with batch traceability

Lab Verification – Third-Party Test Results

At Dragon Pharma, every batch of Helios undergoes independent third-party HPLC testing to verify concentration, purity, and sterility. Below are test results for recent batches, analyzed by Analiza Bialek.

Lab file

helios-lab-test-2025-11-20

Test Date

2025-11-20

Batch Number

HELIBG9

Measured Result

Clenbuterol: 43.28 mcg | Yohimbine: 5.27 mg

Assay vs Label

Clen: 54.1% | Yoh: 105.4%

COA summary: both actives verified, purity passed, sterility passed.

Latest Batch

Why Third-Party Testing Matters

Dual-active blends require particularly rigorous quality control to ensure accurate ratios of both compounds. Independent laboratory verification is the only reliable method to confirm product integrity. Dragon Pharma commits to full transparency – every batch is tested, and COAs are published here as they become available.

For more information on adrenergic receptor research and lipolysis pathways, refer to this PubMed study on adrenergic signaling.

Shipping & Product Authenticity

What to Expect

• ✔ Orders processed within 24–48 hours after payment confirmation
• ✔ USA Domestic shipping via USPS/UPS/FedEx – tracking included
• ✔ International tracking available (update frequency varies by destination)
• ✔ Vials shipped in protective packaging with tamper-evident seals

How to Verify You Have Legit Helios

Counterfeit research compounds are a real problem. Here's how to confirm you are getting authentic Dragon Pharma Helios:

• ✔ QR code verification – each box includes a unique QR code. Scan it to verify the batch on Dragon Pharma's official database
• ✔ Scratch-off serial number – reveals a one-time use code for online verification
• ✔ Batch traceability – match the batch number on the vial to lab test results above
• ✔ Original crimp seal – intact, sterile vial with Dragon Pharma labeling

For complete delivery details, tracking policy, international customs, and reshipment terms, please see our Shipping Info page.

Storage Guidelines

Storage Recommendations

• ✔ Store at 15–25°C (59–77°F) – controlled room temperature
• ✔ Do not freeze – freezing can cause precipitation
• ✔ Keep in original packaging, away from direct light and moisture
• ✔ Stable for up to 24 months when stored properly
• ✔ Avoid repeated temperature fluctuations

What to Avoid

• ❌ Freezing – damages oil-based solution stability
• ❌ Leaving at extreme temperatures (>30°C) – accelerates degradation
• ❌ Shaking the vial vigorously – roll gently to mix if needed
• ❌ Using solution that appears cloudy or contains visible particles
• ❌ Storing in bathroom or near heat sources

Inspection Before Use

Before using in your research, always inspect the vial:

• ✔ Solution should be clear to pale yellow, free from particles
• ✔ Crimp seal must be intact – do not use if seal is broken or missing
• ✔ Check batch number and QR code for authenticity before first use

Keep out of reach of children and unauthorized personnel. Follow institutional laboratory safety guidelines for handling research compounds.

Frequently Asked Questions